Latest Drug Enforcement Administration Stories
LUTHERVILLE, Md., Feb. 8, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) - a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion - today lauded the results achieved by the real-time, stop-sale system in Missouri during 2011. Data released by the National Precursor Log...
LUTHERVILLE, Md., Feb. 6, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) - a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion - today lauded the results achieved by the real-time, stop-sale system in Kentucky. Throughout 2011, results released by the National Precursor Log...
DUBLIN, Ohio, Feb. 3, 2012 /PRNewswire/ -- Today Cardinal Health was granted a temporary restraining order against the Drug Enforcement Administration's (DEA) immediate suspension order of its Lakeland, Fla. DEA registration. U.S. District Court for the District of Columbia Judge Reggie B. Walton granted the temporary restraining order that allows Cardinal Health to immediately resume shipments of controlled medicines from its Lakeland facility to hospital and pharmacy...
DUBLIN, Ohio, Feb. 3, 2012 /PRNewswire/ -- Cardinal Health, one of the nation's largest health care distributors, today said it will vigorously contest the Drug Enforcement Administration's (DEA) immediate suspension of its license to distribute controlled medicines from the company's Lakeland, Fla., distribution center and will ask a federal court to block the DEA's efforts. In documents to be filed with the U.S. District Court for the District of Columbia, Cardinal Health asserts...
LUTHERVILLE, Md., Jan. 30, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) - a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion - today released the following statement in reaction to proponent testimony in the Ohio House of Representatives on House Bill 334. "We strongly...
RANCHO CORDOVA, Calif., Jan. 25, 2012 /PRNewswire/ -- AMPAC Fine Chemicals LLC (AFC), a wholly owned subsidiary of American Pacific Corporation (Nasdaq: APFC), announced today that is has been granted Registration as a Manufacturer of Controlled Substances from the U.S. Drug Enforcement Agency (DEA). AFC has been involved in the development of Schedule II Controlled Substances since 2008 under a Researcher's License from the DEA. Recent facilities upgrades have expanded AFC's...
The UK-based pharmaceutical company, GW Pharma, is testing medicines derived from cannabis in anticipation of a relaxation of federal laws banning the plant from American pharmacy shelves. Advanced clinical trials are underway for a mouth spray for lessening cancer pain developed from raw marijuana. FDA approval is expected by the end of next year, reports Claire Bates for the Daily Mail UK. The US Drug Enforcement Administration (DEA) categorizes pot as a dangerous drug with no medical...
The Drug Enforcement Administration is expected to approve electronic prescribing vendors to allow the transmission of Schedule II Controlled Substance Orders in the very near future. This much anticipated and desired move by the DEA will dramatically improve efficiency for all prescribers, especially hospice clinicians and nurses. Delta Care Rx is the first and only Hospice Pharmacy Benefit Manager in the country to provide proprietary and certified e-Prescribing at no charge to all...
Patients suffering from attention deficit hyperactivity disorder (ADHD) can expect continued difficulty obtaining medicine to treat the ailment, recent published reports suggest. According to Toni Clarke of Reuters, shortages of medications like Adderall, a stimulant used to control ADHD symptoms, are due in part because they are regulated by the Drug Enforcement Agency (DEA) as a controlled substance. In other words, because the drug is addictive, the DEA can place strict regulations on...
Drug companies are working to develop a prescription painkiller much more powerful than Vicodin, worrying addiction experts that it could lead to a new wave of drug abuse. With prescription painkiller abuse treatment climbing 430 percent over the past decade, addiction experts and drug control advocates are concerned that a new mega-dose of hydrocodone, the powerful ingredient found in the drugs Vicodin and OxyContin, will make things worse. The new painkiller has up to 10 times the...
